[1]Nicholson LK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica, 1999, 29(11):1181-1189. [2]Lindon JC, Holmes E, Nicholson JK. Pattern recognition Methods and applications in biomedical magnetic resonance[J]. Prog NMRS, 2001, 39(1):1-40. [3]Nicholson JK, Connelly J, Lindon JC, et al. Metabono- mics: a platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2):153-161. [4]Dossing M, Wilcke JTR, Askgaard DS, et al. Liver injury during antituberculosis treatment: an 11-year study[J]. Tuberc Lung Dis, 1996, 77(4):335-340. [5]Sinder DE, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information[J]. Am Reu Respir Dis, 1992, 145(2 Pt1):494-497. [6]廖艳,彭双清,颜贤忠. 利福平致肝毒性的代谢组学特征研究[J]. 中国新药杂志, 2007, 16(16):1260-1265. [7]Nicholson JK, Buckingham MJ, Ssdler PJ. High resolution proton NMR studies of vertebrate blood and plasma[J]. Biochem J, 1983, 211(3):605-615. [8]Gavaghan CL, Holmes E, Lenz E, et al. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences; application to the C57BL10J and Alpk: ApfCD mouse[J]. FEBS Lett, 2000, 484(3):169-174. [9]Azmi J, Griffin JL, Antti H, et al. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data[J]. Analyst, 2002, 127(2):271-276. [10]Nicholls AW, Holmes E, Lindon JC, et al. Metabonomic investigations into hydrazine toxicity in the rat[J]. Chem Res Toxicol, 2001, 14(8):975-987. [11]Robertson DG, Reily MD, Sigler RE, et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants[J]. Toxicol Sci, 2000, 57(2):326-337. [12]Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity[J]. Toxicol Sci, 2002, 65(2):166-176. [13]Griffin JL, Bollard ME. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration[J]. Curr Drug Metab,2004, 5(5):389-398. [14]Lenz EM, Wilson ID. Analytical strategies in metabonomics[J].J Proteome Res,2007, 6(2):443-458. [15]Robertson DG, Reily MD, Baker JD. Metabonomics in pharmaceutical discovery and development[J].J Proteome Res,2007, 6(2):526-539. [16]Yuan KL, Kong HW, Guan YF, et al. A GC-based metabonomics investigation of type 2 diabetes by organic acids me- tabolic profile[J].J Chromatogr B,2007, 850(1-2):236-240.
|